Impact of Perioperative Nutritional Status and Management in the Context of Resectable Pancreatic Adenocarcinoma

Patients with pancreatic adenocarcinoma are frequently in a situation of malnutrition, in a context of functional alteration of the digestive tract, and hypercatabolism.

As a result, nutritional support is frequently necessary perioperatively, but currently does not follow a specific protocol, and without coordination.

It then appears the need to evaluate the prevalence of malnutrition, its impact on perioperative morbidity and mortality, and current management methods.

Depending on the findings, subsequent interventional studies will be carried out on the subject, exploring the different modalities of artificial nutrition.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pancreatic Adenocarcinoma Malnutrition Nutrition Disorders Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service de Chirurgie Viscérale et Digestive - CHU de Strasbourg - France

Strasbourg, 67091, France

Location status: Recruiting

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Major subject (≥18 years old)
Subject with pancreatic adenocarcinoma authenticated by pathology
Subject candidate for curative surgical treatment
Subject operated on in the visceral and digestive surgery department, NHC Strasbourg, during the period from January 1, 2018 to December 31, 2022
Absence of written opposition in the subject's medical file to the reuse of their data for scientific research purposes.

Exclusion criteria

Subject having expressed opposition to participating in the study
Subject presenting a metastatic form or one not accessible to surgical treatment considered curative of pancreatic adenocarcinoma
Subject under guardianship or curatorship
Subje

Treatment and study plan

Primary outcomes

Study of the Severity of Perioperative Malnutrition in Pancreatic Adenocarcinoma

Time frame: Up to 1 year

The CCI score measures a patient's postoperative outcome based on the number and severity of complications occurring on a scale of 0 to 100:

0: No complications 100: Death

Interested in participating?

Recruiting

Interested in participating?

Request Info

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: PAAD

Important dates

Study start: 2023
Primary completion: 2025
Study completion: 2025
First posted: Mar 25, 2025
Registry last updated: Mar 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting